Ranbaxy Laboratories, facing a host of regulatory issues, has recalled over 64,000 bottles of the generic version of a cholesterol-lowering drug, Lipitor, in the US after a dosage mix-up was detected. It recalled the tablets of atorvastatin calcium after a pharmacist found a 20mg tablet in a sealed bottle marked for 10mg tablets, the US Food and Drug Administration said on its website.
Ranbaxy, India’s biggest drugmaker by revenue and majority owned by Japan’s Daiichi Sankyo, confirmed the recall of select batches of the drug. But it said the company had not received any product complaints. The recall is being conducted at the retail level. A company spokesperson said Ranbaxy is proactively recalling the lots out of an abundance of caution, keeping the safety of its patients in mind and with the full knowledge of the US FDA.
The recall is the latest in a series of problems to hit Ranbaxy, which has had all its domestic units banned from sending drugs and ingredients to the US, its biggest market.
via Ranbaxy calls back cholesterol drug in US – The Times of India.
US Immigration and Customs Enforcement (ICE) has confirmed that 750 detainees at the Northwest Detention Center in Washington state have refused to eat and say they are on a hunger strike.
via Hunger strike by 750 immigrants at Washington state detention centre | World news | theguardian.com.